Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Brinkbäumer

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Nuclear Medicine Communications|December 29, 2000
Is a low-dose Tc-99m-MIBI protocol suitable for first-pass RNV?A Tausig, P Knesewitsch, K Brinkbäumer, et al.
Nuklearmedizin. Nuclear Medicine|September 16, 2005
[Lymph kinetics with technetium-99m labeled radiopharmaceuticals. Animal studies]M Weiss, F J Gildehaus, K Brinkbäumer, et al.
Onkologie|March 8, 2003
Breast cancer: monitoring response to neoadjuvant chemotherapy using Tc-99m sestamibi scintimammographyR Tiling, M Kessler, M Untch, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 10, 2003
[18F]FDG imaging of head and neck tumours: comparison of hybrid PET and morphological methodsS Dresel, J Grammerstorff, K Schwenzer, et al.
European Journal of Nuclear Medicine|July 7, 2001
18F-FDG PET and 99mTc-sestamibi scintimammography for monitoring breast cancer response to neoadjuvant chemotherapy: a comparative studyR Tiling, R Linke, M Untch, et al.
Nuklearmedizin. Nuclear Medicine|December 1, 2001
[[F-18]FDG imaging of head and neck tumors: comparison of hybrid PET, dedicated PET and CT]S Dresel, K Schwenzer, K Brinkbäumer, et al.
Nuklearmedizin. Nuclear Medicine|July 12, 2002
[Breast scintigraphy using 99mTc-sestamibi--use and limitations]R Tiling, R Linke, M Kessler, et al.
European Journal of Nuclear Medicine|November 18, 2000
Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatmentS Dresel, J Krause, K H Krause, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Nuclear Medicine Communications|December 29, 2000
Is a low-dose Tc-99m-MIBI protocol suitable for first-pass RNV?A Tausig, P Knesewitsch, K Brinkbäumer, et al.
Nuklearmedizin. Nuclear Medicine|September 16, 2005
[Lymph kinetics with technetium-99m labeled radiopharmaceuticals. Animal studies]M Weiss, F J Gildehaus, K Brinkbäumer, et al.
Onkologie|March 8, 2003
Breast cancer: monitoring response to neoadjuvant chemotherapy using Tc-99m sestamibi scintimammographyR Tiling, M Kessler, M Untch, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 10, 2003
[18F]FDG imaging of head and neck tumours: comparison of hybrid PET and morphological methodsS Dresel, J Grammerstorff, K Schwenzer, et al.
European Journal of Nuclear Medicine|July 7, 2001
18F-FDG PET and 99mTc-sestamibi scintimammography for monitoring breast cancer response to neoadjuvant chemotherapy: a comparative studyR Tiling, R Linke, M Untch, et al.
Nuklearmedizin. Nuclear Medicine|December 1, 2001
[[F-18]FDG imaging of head and neck tumors: comparison of hybrid PET, dedicated PET and CT]S Dresel, K Schwenzer, K Brinkbäumer, et al.
Nuklearmedizin. Nuclear Medicine|July 12, 2002
[Breast scintigraphy using 99mTc-sestamibi--use and limitations]R Tiling, R Linke, M Kessler, et al.
European Journal of Nuclear Medicine|November 18, 2000
Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatmentS Dresel, J Krause, K H Krause, et al.
Pageof 1